Skip to main content
. 2023 Feb 7;16(2):254. doi: 10.3390/ph16020254

Table 2.

The anticancer activity of N-(2,4-dimethylphenyl)-5-(4-hydroxyphenyl)-1,3,4-oxadiazol-2-amine against various cell lines.

Cell Lines K-562
(Leukemia)
MDA-MB-435 (Melanoma) HCT-15
(Colon Cancer)
T-47D
(Breast Cancer)
Growth percent (GP) 18.22 15.43 39.77 34.27